Breast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET).

2.50
Hdl Handle:
http://hdl.handle.net/10541/77894
Title:
Breast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET).
Authors:
Malinovszky, K M; Cameron, David; Douglas, S; Love, C; Leonard, T; Dixon, J M; Hopwood, Penelope; Leonard, R C F
Abstract:
Women with hormone responsive breast cancer routinely receive endocrine therapy. There is growing evidence that patients experience significant side effects. Between 1996 and 1998, all patients on endocrine therapy for adjuvant or advanced breast cancer, attending the Edinburgh Breast Unit, were invited to complete a checklist for patients on endocrine therapy. This simple form, designed as a communication aid, was completed by patients before their consultation. 708 patients (age 28-93) completed 1060 forms. These forms were analysed in order to gain a better understanding of the side effects experienced. Most patients were on tamoxifen (n = 524), with 103 on anastrazole and 35 on megestrol acetate. Common symptoms experienced were hot flushes, sweats and weight gain. Symptoms varied according to the patients' ages and the setting in which they received endocrine treatment. Pre-menopausal women were more likely to experience problems with flushes, sweats, weight gain and reduced libido.
Affiliation:
South West Wales Cancer Institute, Singleton Hospital, Swansea SA2 8QA, UK. kathy.malinovszky@swansea-tr.wales.nhs.uk
Citation:
Breast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET). 2004, 13 (5):363-8 Breast
Journal:
Breast
Issue Date:
Oct-2004
URI:
http://hdl.handle.net/10541/77894
DOI:
10.1016/j.breast.2004.02.009
PubMed ID:
15454190
Type:
Article
Language:
en
ISSN:
0960-9776
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorMalinovszky, K M-
dc.contributor.authorCameron, David-
dc.contributor.authorDouglas, S-
dc.contributor.authorLove, C-
dc.contributor.authorLeonard, T-
dc.contributor.authorDixon, J M-
dc.contributor.authorHopwood, Penelope-
dc.contributor.authorLeonard, R C F-
dc.date.accessioned2009-08-19T14:50:46Z-
dc.date.available2009-08-19T14:50:46Z-
dc.date.issued2004-10-
dc.identifier.citationBreast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET). 2004, 13 (5):363-8 Breasten
dc.identifier.issn0960-9776-
dc.identifier.pmid15454190-
dc.identifier.doi10.1016/j.breast.2004.02.009-
dc.identifier.urihttp://hdl.handle.net/10541/77894-
dc.description.abstractWomen with hormone responsive breast cancer routinely receive endocrine therapy. There is growing evidence that patients experience significant side effects. Between 1996 and 1998, all patients on endocrine therapy for adjuvant or advanced breast cancer, attending the Edinburgh Breast Unit, were invited to complete a checklist for patients on endocrine therapy. This simple form, designed as a communication aid, was completed by patients before their consultation. 708 patients (age 28-93) completed 1060 forms. These forms were analysed in order to gain a better understanding of the side effects experienced. Most patients were on tamoxifen (n = 524), with 103 on anastrazole and 35 on megestrol acetate. Common symptoms experienced were hot flushes, sweats and weight gain. Symptoms varied according to the patients' ages and the setting in which they received endocrine treatment. Pre-menopausal women were more likely to experience problems with flushes, sweats, weight gain and reduced libido.en
dc.language.isoenen
dc.subjectBreast Canceren
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshAntineoplastic Agents, Hormonal-
dc.subject.meshBreast Neoplasms-
dc.subject.meshFemale-
dc.subject.meshHealth Surveys-
dc.subject.meshHumans-
dc.subject.meshMiddle Aged-
dc.titleBreast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET).en
dc.typeArticleen
dc.contributor.departmentSouth West Wales Cancer Institute, Singleton Hospital, Swansea SA2 8QA, UK. kathy.malinovszky@swansea-tr.wales.nhs.uken
dc.identifier.journalBreasten

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.